Rumour of the week: Schering/Novartis
Last week the talk of the town was Aventis and potential mergers with Sanofi-Synthelabo or Procter & Gamble.
Last week the talk of the town was Aventis and potential mergers with Sanofi-Synthelabo or Procter & Gamble.
A US congressional committee has asked five drug makers for advice on the measures they are taking to combat the counterfeiting and diversion of prescription drugs.
Dr Reddy's Laboratories has developed a new class of therapeutic that could make it the first pharmaceutical company in India to develop a proprietary blockbuster product.
The number of novel pharmaceutical compounds approved for marketing - a traditional benchmark for the industry's R&D performance - has seen a welcome increase after years of declines.